Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

The purpose of this study was to determine whether epirubicin, cisplatin and infused 5FU (ECF) improves overall survival (OS) compared to 5FU, etoposide and leucovorin (FELV) in patients with previously untreated advanced biliary cancer in a prospective randomised study. Patients were randomly assig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rao, S, Cunningham, D, Hawkins, R E, Hill, M E, Smith, D, Daniel, F, Ross, P J, Oates, J, Norman, A R
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2005
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362051/
https://ncbi.nlm.nih.gov/pubmed/15856037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602576
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados